''The stage is now set for ultimate resolution of this thing," said Director Kenneth Endicott of the National Cancer Institute last week, with a vast sigh of relief. Under last year's tightened drug-control laws, the Food and Drug Administration is at last launching an all-out investigation to answer a question that has caused savage controversy for twelve years: Is there any basis for the claims that Krebiozen, a mysterious horse-serum drug, is a cure for some forms of cancer? Though Krebiozen has never been approved by any federal agency, about 3,500 doctors...
To continue reading:
or
Log-In
